Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
173 hedge funds and large institutions have $3.09B invested in Intercept Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 86 increasing their positions, 45 reducing their positions, and 36 closing their positions.
91% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 45
9% less funds holding
Funds holding: 191 → 173 (-18)
14% less call options, than puts
Call options by funds: $76.7M | Put options by funds: $88.8M
29% less capital invested
Capital invested by funds: $4.36B → $3.09B (-$1.27B)
47% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 36
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$139M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$77.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$47.9M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.8M |
| 5 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWG
Alpha Wave Global
New York
|
-$39.5M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$32.3M |
| 3 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$27.8M |
| 4 |
FAM
Fred Alger Management
New York
|
-$25.8M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$22M |
ICPT Hedge Fund Activity: Q3 2015 in Review
173 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q3 2015, worth a combined $3.09B — down 29% from $4.36B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of ICPT and 19 opened new positions — a net loss of 17 holders — while 45 trimmed existing stakes and 86 added.
The largest buyer was Capital World Investors, adding an estimated $139M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $39.5M sold.
- 173 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q3 2015, down from 191 in Q2 2015.
- Funds reported $3.09B of Intercept Pharmaceuticals, Inc. stock for Q3 2015, down 29% quarter-over-quarter.
- 19 funds opened new Intercept Pharmaceuticals, Inc. positions in Q3 2015 and 36 closed out, a net change of -17 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q3 2015 was Capital World Investors, an estimated $139M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q3 2015 was Alpha Wave Global, an estimated $39.5M sold.
Based on aggregated 13F filings for Q3 2015.